Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche adds a slate of PhIII schizophrenia trial failures to bitopertin's obituary
Fierce Biotech
Wednesday, April 16, 2014 - 9:10am
tags:
bitopertin, Roche, schizophrenia
FDA Formally Withdraws Approval for Second Generic Version of Popular Antidepressant
Regulatory Focus
Wednesday, April 16, 2014 - 9:08am
tags:
FDA, generics, GSK, antidepressants, Wellbutrin XL, Watson Pharmaceuticals
Abbott First-Quarter Profit Beats Estimates on Diagnostic Tests
Bloomberg
Wednesday, April 16, 2014 - 9:07am
tags:
Abbott Labs, earnings
Here’s Why Johnson & Johnson Had a Crazy Good First Quarter
Wall St Cheat Sheet
Wednesday, April 16, 2014 - 8:51am
tags:
JNJ, earnings
FDA OKs new generation Boston Scientific heart pacing devices
Yahoo/Reuters
Wednesday, April 16, 2014 - 8:40am
tags:
Implantable cardioverter defibrillators, arrhythmias, Boston Scientific, devices, FDA, Dynagen X4, Inogen Mini, Dynagen Mini, Inogen X4
Zogenix Wins Order Blocking Massachusetts Ban on Painkiller
Bloomberg
Wednesday, April 16, 2014 - 8:37am
tags:
Zogenix, Massachusetts, Zohydro
Reckitt leans towards pharmaceuticals spin-off
Yahoo/Reuters
Wednesday, April 16, 2014 - 8:35am
tags:
spinoffs, Reckitt Benckiser
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tuesday, April 15, 2014 - 4:49pm
tags:
FDA, Eli Lilly, Boehringer Ingelheim, Trajenta, empagliflozin, diabetes, type 2 diabetes
Will St. Jude Medical (STJ) Surprise This Earnings Season?
Yahoo/Zacks.com
Tuesday, April 15, 2014 - 4:48pm
tags:
devices, earnings, St. Jude Medical
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
Motley Fool
Tuesday, April 15, 2014 - 1:50pm
tags:
Puma Biotechnology, Macrogenics, neratinib, Aratana, MGD007
Teva announces launch of generic Lunesta tablets in U.S.
Yahoo/Fly on the Wall
Tuesday, April 15, 2014 - 1:48pm
tags:
Lunesta, insomnia, generics, Teva Pharmaceuticals, Sunovion
Report: US prescription spending rises 3.2 pct in 2013, as prices climb, generic impact wanes
Yahoo/AP
Tuesday, April 15, 2014 - 1:47pm
tags:
prescription data, drug spending, generics
Angion swings for a $36M IPO as biotech's bear turn drags on
Fierce Biotech
Tuesday, April 15, 2014 - 10:57am
tags:
Angion, IPOs
GE Healthcare lands FDA nod for all-in-one CT
Mass Device
Tuesday, April 15, 2014 - 10:55am
tags:
GE Healthcare, FDA, CT Scan, devices, Revolution CT
Ziopharm: Attempting To Rise Again In A Crowded Space
Seeking Alpha
Tuesday, April 15, 2014 - 10:53am
tags:
Ziopharm
Novartis marks 235 admin jobs for deletion amid companywide restructuring
Fierce Pharma
Tuesday, April 15, 2014 - 10:43am
tags:
Novartis, restructuring, layoffs
Puma Biotechnology: ISPY2 Data Added Little To The Neratinib Conversation
Seeking Alpha
Tuesday, April 15, 2014 - 10:40am
tags:
Puma Biotechnology, neratinib, breast cancer
Boehringer 2013 profit up on Pradaxa sales, cost cuts
Reuters
Tuesday, April 15, 2014 - 10:37am
tags:
earnings, Boehringer Ingelheim
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Motley Fool
Tuesday, April 15, 2014 - 10:36am
tags:
hepatitis C, Gilead Sciences, Sovaldi, Merck, Bristol-Myers Squibb, daclatasvir, asunaprevir, MK-5172, MK-8742
Big Pharma's Turn On RNAi Shows That New Technologies Don't Guarantee R&D Success
Forbes
Tuesday, April 15, 2014 - 10:35am
tags:
Big Pharma, RNAi, Novartis, Alnylam

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.